Pascal Soriot

From WikiProjectMed
Jump to navigation Jump to search

Sir
Pascal Soriot
Soriot in 2019
Born
Pascal Claude Roland Soriot

(1959-05-23) 23 May 1959 (age 64)
France
Citizenship
  • French
  • Australian
EducationÉcole nationale vétérinaire d'Alfort
HEC Paris
OccupationBusinessman
Years active1982–present
TitleCEO, AstraZeneca
Term2012–
Children2
HonoursKnight Bachelor

Sir Pascal Claude Roland Soriot (born 23 May 1959) is a French-born Australian businessman and chief executive officer (CEO) of the British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca.[1]

Early life

Pascal Soriot was born in France on 23 May 1959.[2] His father died when he was 20.[3]

He studied veterinary medicine at the École nationale vétérinaire d'Alfort at Maisons-Alfort in Paris.[2] He later obtained an MBA at HEC Paris.[1]

Career

Roussel Uclaf

In April 1986, he joined Roussel Uclaf (formerly France's second largest pharmaceutical company, until bought by Hoechst AG in 1997) as a salesman in Australia.[2][4] In 1996, he became General Manager of Hoechst Marion Roussel in Australia, moving to Tokyo in April 1997.[5]

Aventis

In 2000 he moved to Aventis in America, becoming chief operating officer of Aventis USA in 2002, which became Sanofi Aventis USA in 2004.[6][7]

Roche

He joined Roche in 2006 as head of marketing.[8] From April 2009 to 2010, he was chief executive of the Roche subsidiary Genentech. He rejoined Roche Pharma AG in 2010 as chief operating officer.[9]

AstraZeneca

In August 2012 he was named as the new chief executive of AstraZeneca,[10] the world's fifth largest pharmaceutical company, when aged 53. He took up the post on 1 October 2012.[11][12]

In July 2017, it was reported that Soriot would become the next CEO of Israel-based Teva Pharmaceutical Industries, succeeding Erez Vigodman, though this was soon denied.[13][14][15]

In September 2018, he made headlines commenting on his pay of £9.4m in salary and bonuses. 'The truth is I’m the lowest-paid CEO in the whole industry', he said. 'It is annoying to some extent. But at the end of the day it is what it is.'[16]

In 2023, Soriot was the highest paid CEO of the major European pharmaceutical companies, as he earned $21.3 million.That was a nearly 12% increase over 2022.[17]

Personal life

He is married and has two children.[18] He has three brothers, all of whom are doctors.[3]

Soriot was knighted in the 2022 Birthday Honours for services to UK life sciences and the response to COVID-19.[19] He qualifies for a substantive knighthood rather than an honorary one by virtue of being an Australian citizen.[20]

He counts cycling, horse riding and skiing as hobbies.[21]

References

  1. ^ a b "Executive Profile: Pascal Soriot". Bloomberg. Retrieved 3 April 2015.
  2. ^ a b c "Pascal Soriot: Leader of the great escape". Financial Times. June 2014. Archived from the original on 4 March 2023. Retrieved 26 January 2017.
  3. ^ a b Ralph, Alex (17 May 2019). "A drugs giant that loves to blind rivals with science". The Times. ISSN 0140-0460. Retrieved 17 May 2019.
  4. ^ "Pascal Soriot". Roche.com. Retrieved 26 January 2017.
  5. ^ Ward, Andrew (21 January 2016). "Pascal Soriot on his rise to become CEO of AstraZeneca". Financial Times. Retrieved 8 March 2024.
  6. ^ "Roche | Pascal Soriot". www.roche.com. Retrieved 8 March 2024.
  7. ^ "SANOFI-AVENTIS". www.sec.gov. Retrieved 8 March 2024.
  8. ^ Ward, Andrew (21 January 2016). "Pascal Soriot on his rise to become CEO of AstraZeneca". Financial Times. Retrieved 8 March 2024.
  9. ^ "AstraZeneca Names Roche's Pascal Soriot as CEO". Bloomberg. 28 August 2012. Retrieved 6 February 2013.
  10. ^ Rowley, Emma (28 August 2012). "AstraZeneca appoints Roche's Pascal Soriot as new chief". The Telegraph. Retrieved 26 January 2017.
  11. ^ Kollewe, Julia (28 August 2012). "AstraZeneca appoints new chief executive". The Guardian. ISSN 0261-3077. Retrieved 8 March 2024.
  12. ^ "AstraZeneca Names Its Next Chief". The New York Times. 28 August 2012. ISSN 0362-4331. Retrieved 8 March 2024.
  13. ^ Boland, Hannah (14 July 2017). "Pascal Soriot looks set to stay as AstraZeneca chief". The Telegraph – via www.telegraph.co.uk.
  14. ^ "AstraZeneca's CEO Soriot to join Israeli drugs company Teva: report". Reuters. 14 May 2014. Retrieved 12 July 2017.
  15. ^ "Israeli newspaper reports that AstraZeneca CEO Pascal Soriot has agreed to take the helm at Teva – ENDPOINTS NEWS". Endpts.com. Retrieved 12 July 2017.
  16. ^ Meddings, Sabah (6 October 2023). "Salary size matters, says Astra Zeneca boss on £9.4m" – via www.thetimes.co.uk.
  17. ^ Staff, A. O. L. (5 March 2024). "Worse than COVID shutdown. Pasco businesses in dire straits over overpass closure project". www.aol.com. Retrieved 7 March 2024.
  18. ^ James Ashton (16 May 2014). "Astrazeneca chief Pascal Soriot: I can carry on curing the company, says scientist in £63bn bid battle". Standard.co.uk. Retrieved 26 January 2017.
  19. ^ "No. 63714". The London Gazette (Supplement). 1 June 2022. p. B2.
  20. ^ "AstraZeneca's Pascal Soriot awarded British knighthood for services to UK life sciences and leadership in the global response to the COVID pandemic". AstraZeneca.com. Retrieved 14 June 2022.
  21. ^ Ward, Andrew (21 January 2016). "Pascal Soriot on his rise to become CEO of AstraZeneca". Financial Times. Retrieved 8 March 2024.

External links

Business positions
Preceded by Chief Executive of AstraZeneca
2012–present 		Succeeded by
Incumbent
Preceded by
 Chief Operating Officer of Hoffmann-La Roche
2010–2012 		Succeeded by
Daniel O'Day
Preceded by
 Chief Executive of Genentech
2009–2010 		Succeeded by
Ian Clark
Retrieved from "https://mdwiki.org/wiki/Pascal_Soriot"